Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: Molecular testing as a helpful diagnostic tool for Netherton syndrome

E. Sprecher*, A. Tesfaye-Kedjela, P. Ratajczak, R. Bergman, G. Richard

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The congenital erythrodermas represent a heterogeneous group of inherited and acquired disorders often accompanied by systemic infections, impaired epidermal barrier function and concomitant life-threatening fluid and electrolyte imbalance. In the present report, we describe a patient who was considered to have congenital ichthyosiform erythroderma for 26 years until molecular testing led to the correct diagnosis of Netherton syndrome.

Original languageEnglish
Pages (from-to)513-517
Number of pages5
JournalClinical and Experimental Dermatology
Volume29
Issue number5
DOIs
StatePublished - Sep 2004
Externally publishedYes

Funding

FundersFunder number
National Institute of Arthritis and Musculoskeletal and Skin DiseasesP01AR038923

    Fingerprint

    Dive into the research topics of 'Deleterious mutations in SPINK5 in a patient with congenital ichthyosiform erythroderma: Molecular testing as a helpful diagnostic tool for Netherton syndrome'. Together they form a unique fingerprint.

    Cite this